Our data show that the expansion of tumor antigen–specific CD8+ T cells following short-course ATRi plus RT is driven by proinflammatory cytokine and chemokine signaling in the TME and downstream communication of that signaling (via immune cell migration) to the DLN. Here, CD8A is linked to neoplasm.